增强型体外反搏在男科的应用研究进展  

Progress in the Application of Enhanced External Counterpulsation in Andrology

作　　者：翟嘉文 玄绪军[1] ZHAI Jiawen;XUAN Xujun(Department of Andrology,The Seventh Affiliated Hospital of Sun Yat-sen University,Shenzhen 518107,China)

机构地区：[1]中山大学附属第七医院男科,广东深圳518107

出　　处：《中山大学学报(医学科学版)》2025年第2期238-244,共7页Journal of Sun Yat-Sen University:Medical Sciences

基　　金：中山大学附属第七医院临床医学研究“735”计划(ZSOY202373518)。

摘　　要：体外反搏(ECP)技术是一种无创性辅助循环治疗手段,自1962年开始应用于临床实践,最初主要是用于治疗心脑血管疾病。在过去的四十年中,随着医学技术的深入研究与进步,体外反搏进一步发展为增强型体外反搏(EECP)。EECP通过增加器官的灌注压力和血流量,具有改善血管内皮细胞功能、促进血液循环以及代谢等功能。鉴于其在安全性、有效性及经济性方面的优势,EECP不仅在心脑血管疾病临床治疗中发挥着重要作用,还逐渐扩展至包括男科疾病在内的多个领域,为男科疾病的治疗提供了新的治疗选择与思路。特别是在男性勃起功能障碍(ED)的治疗领域,EECP展现出显著的潜力,并积累了一定的临床实践经验和科研成果。研究表明,ED的发生与血管内皮功能障碍、微循环异常等因素密切相关,而EECP通过改善血管内皮功能和全身健康状态,能够有效改善ED患者的症状,提升治疗效果。本文旨在综合国内外相关报道,对EECP在男科疾病治疗中的应用研究进行全面总结,重点分析其在ED治疗中的临床效果及作用机制,并探讨其在其他男科疾病中的潜在应用价值。同时,本文也对当前研究中存在的不足进行分析,并对未来的研究方向进行展望分析,以期为EECP在男科疾病治疗中的应用提供更为坚实的科学依据和参考。External counterpulsation(ECP)technology represents a non-invasive adjunctive circulation treatment approach implemented in clinical practice since 1962,initially focused on managing cardio-cerebrovascular diseases.Over the past four decades,continuous research and advancements in medical technology have facilitated the evolution of enhanced external counterpulsation(EECP).This therapeutic modality can enhance the function of vascular endothelial cells,promote blood circulation,and improve metabolism by increasing organ perfusion pressure and blood flow.Given its demonstrated safety,efficacy,and cost-effectiveness,EECP has not only played a significant role in the clinical treatment of cardio-cerebrovascular diseases but also expanded into diverse domains,including andrology,which provides new therapeutic avenues for various health concerns.Particularly in the treatment of male erectile dysfunction(ED),EECP has shown remarkable potential,and certain clinical practice experience and scientific research results are accumulated.Research indicates that the occurrence of ED is closely associated with endothelial dysfunction and microcirculatory issues.EECP has been shown to effectively alleviate symptoms in ED patients and improve treatment outcomes by optimizing endothelial function and overall systemic health.This article reviews relevant findings from both domestic and international sources,summarizing the current research on the application of EECP in treating andrological diseases.It focuses on analyzing its clinical effects and mechanisms in treating ED and explores potential applications in other male urological conditions.Additionally,this paper discusses the limitations of current research and offers insights into future research directions to provide a more robust scientific basis and references for the use of EECP in managing andrological diseases.

关 键 词：增强型体外反搏 男科 勃起功能障碍 血管内皮细胞 

分 类 号：R698.1[医药卫生—泌尿科学]